Previous studies have demonstrated that pyroptosis-related genes can be used as new diagnostic and prognostic markers for tumors and contribute to the sensitivity analysis of immunotherapy, especially CHMP4C has an important role in cervical cancer, hepatocellular carcinoma and bladder cancer prognostic models (27) (28) (29). This evidence concerns the gene CHMP4C and cervical carcinoma.